METASTATIC TRIPLE NEGATIVE BREAST CANCER
Clinical trials for METASTATIC TRIPLE NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat breast cancer patients in china
Disease control OngoingThis study is testing how well a drug called sacituzumab govitecan works for Chinese patients with advanced triple-negative breast cancer that has continued to grow despite at least two prior chemotherapy treatments. The main goal is to see how many patients' tumors shrink in res…
Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough breast cancer: testing combo therapy
Disease control OngoingThis study is testing whether adding two new drugs, AK117 and AK112, to standard chemotherapy works better for people with advanced triple-negative breast cancer that has spread. It will involve about 120 patients who have not yet received treatment for their advanced cancer. The…
Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug duos battle tough breast cancer
Disease control OngoingThis study is testing whether adding one of two experimental drugs (ceralasertib or adavosertib) to an existing cancer drug (olaparib) works better than olaparib alone for people with metastatic triple-negative breast cancer. It involves about 273 patients whose cancer has worsen…
Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Four-drug attack on aggressive breast cancer shows promise in new trial
Disease control OngoingThis study is testing whether combining four different cancer drugs works better against advanced triple-negative breast cancer, which is particularly hard to treat. The trial will enroll 36 patients to see if this combination can shrink tumors and control the disease while being…
Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC